Search Results 651-660 of 1543 for 关键词搜索引擎工具咨询邮箱：lgooxc@hotmail.com

  1. Kirk J. Wangensteen, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    Mayo Clinic investigator Kirk J. Wangensteen, M.D., Ph.D., focuses on defining genetic factors involved in liver disease and the development of liver ...

  2. A Study to Evaluate Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma - Mayo Clinic

    A Study to Evaluate Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma · Share ...

  3. Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Mayo Clinic

    Drugs used in chemotherapy, such as carboplatin, paclitaxel, gemcitabine hydrochloride, and pegylated liposomal doxorubicin hydrochloride work in different ways ...

  4. Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia - Mayo Clinic

    Drugs used in chemotherapy, such as cytarabine, work in different ways to stop the growth of cancer cells, either by killing the cells or stopping them from ...

  5. Assessment of Health-related Quality of Life in Primary Hyperoxaluria - Mayo Clinic

    The purpose of this study is to assess the burden that patients and their caregivers face to due primary hyperoxaluria (PH). Participation eligibility.

  6. High-Dose Radiation Therapy Versus Standard Care in Treating Patients With Pancreatic Cancer That Cannot Be Removed By Surgery - Mayo Clinic

    Drugs used in chemotherapy, such as gemcitabine hydrochloride or FOLFIRINOX, work in different ways to stop the growth of tumor cells, either by killing the ...

  7. Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  8. Contact - Pharmacogenomics and Drug Targets Laboratory - Mayo Clinic Research

    Contact. Contact Dr. Wang about her pharmacogenomics research or for information about research training opportunities. Liewei Wang, M.D., Ph.D.

  9. Bedsores Clinical Trials - Mayo Clinic Research

    The purpose of this study will be to 1) determine the risk factors for pressure ulcer development among patients in the pediatric intensive care units in a ...

  10. Study Comparing Veliparib Plus FOLFIRI Versus Placebo Plus FOLFIRI With or Without Bevacizumab in Previously Untreated Metastatic Colorectal Cancer - Mayo Clinic

    FOLFIRI is a chemotherapy regimen of fluorouracil, leucovorin and irinotecan. This is a blinded study such that the Investigator and Subject will be blinded but ...